Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abdominal, adherence, airway, Akin, Allego, appeal, argument, assay, ataxia, beat, Bhatia, bioanalytical, bioengineering, biomarker, biomedical, biosimilar, BLA, bladder, breast, briefly, Brigham, bronchial, Brown, Cerulean, chemotherapy, Chodakewicz, cilia, Clarabridge, clearance, Concert, congestion, cooperate, cooperative, counter, CRISPR, deal, Delaware, disagree, disaster, Dorothy, double, doxorubicin, editing, eighteen, ENaC, epithelial, escalating, extinguishment, faster, Feld, forma, Georgetown, granule, Gump, Hauer, HBE, heard, height, Hematology, hemoglobinapathy, Howard, hydration, incorrect, Innoviva, interchangeability, interchangeable, John, knee, Koch, lieu, liposomal, maker, Merryfield, Michael, Mutual, NaV, neck, neural, noncurrent, notification, opposed, ORKABMI, ORKAMBI, ovarian, pain, Parini, Parion, passed, path, pathway, pegylated, plant, presidential, pro, processing, proliferation, promptly, PTC, query, radiotherapy, recourse, reliant, requisite, Row, Sangeeta, sensation, sickle, sodium, soft, store, subpoena, survival, switching, symptomatic, synthesized, takeover, telangiectasia, telapravir, Title, Tracr, transmit, triple, unwilling, viewed, VII, vital, Wilson
Removed:
adjacent, advancement, announcing, arm, Asia, Assistant, averaging, Bank, Baylor, Ben, biologically, central, chose, collateralize, complicating, connected, consortia, coordinated, create, Dean, declined, declining, decreasing, dedicated, donut, dosed, dual, enablement, excellent, fashion, genotype, Graduate, HCA, highest, hole, hope, Horton, integrated, Iowa, Ireland, Japan, Kenneth, larger, Meharry, Millennium, Morehouse, operator, peak, personalized, Pinnacle, placebo, preempted, preparing, promise, reaching, ribavirin, Rice, Riley, Sidney, statistically, Street, studied, study, target, Taub, TELAVIC, Tropical, Tulane, Vanderbilt, variability, Washington, Waverly, Wayne
Filing tables
Filing exhibits
- 10-K Annual report
- 10.6 Exhibit 10.6
- 10.10 Exhibit 10.10
- 10.25 Exhibit 10.25
- 10.27 Exhibit 10.27
- 10.34 Exhibit 10.34
- 10.35 Exhibit 10.35
- 10.41 Exhibit 10.41
- 10.42 Exhibit 10.42
- 21.1 Exhibit 21.1
- 23.1 Exhibit 23.1
- 31.1 Exhibit 31.1
- 31.2 Exhibit 31.2
- 32.1 Exhibit 32.1
- Download Excel data file
- View Excel data file
Related press release
VRTX similar filings
Filing view
External links
Exhibit 10.42
Vertex Pharmaceuticals Non-Employee Board Compensation | |||
Annual Retainer | $85,000 | ||
Committee Chair Compensation | |||
Audit & Finance Committee Chair | $30,000 annual retainer | ||
Management Development & Compensation Committee Chair | $25,000 annual retainer | ||
Corporate Governance & Nominating Committee Chair | $20,000 annual retainer | ||
Science & Technology Committee Chair | $20,000 annual retainer | ||
Committee Membership Fee (Non Chairs) | |||
Audit & Finance Committee Member | $15,000 annual retainer | ||
Management Development & Compensation Committee Member | $10,000 annual retainer | ||
Corporate Governance & Nominating Committee Member | $10,000 annual retainer | ||
Science & Technology Committee Member | $10,000 annual retainer | ||
Lead Independent Director Compensation | $40,000 annual retainer | ||
Equity Grants | |||
Upon first election to the Board, a $550,000 value-based award, based on a 50/50 mix of restricted stock and options • Options vesting quarterly over four years • Restricted stock vesting annually over four years | |||
On June 1 on each year of service, a $550,000 value-based award, based on a 50/50 mix of restricted stock and options • Options are fully vested upon grant • Restricted shares cliff vest on the 1 year anniversary of the grant date | |||
Each of our non-employee directors is eligible to defer the cash and restricted stock portion of his/her compensation set forth above and elect to receive deferred stock units that convert to common stock in specified circumstances. |